CNPR Certification Revised 14th Edition Is Now Available as the CNPR Becomes More of a Standard With Hundreds of Companies When Hiring Pharmaceutical Sales Rep Candidates

The number of companies looking at the CNPR as a pre-requisite increased over 241% from March of 2013 to April of 2014.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
These pharmaceutical sales training courses and accreditations are for individuals who want to enhance their selling skills to maximize their ability to get hired.

Washington, DC (PRWEB) August 12, 2014

A recent survey conducted in May 2014 shows that the CNPR pharmaceutical sales certification is being used more as a standard qualification when selected candidates to interview as well as hire. The number of companies looking at the CNPR as a pre-requisite increased over 241% from March of 2013 to April of 2014. The survey also showed that companies expect and want entry level pharmaceutical sales rep applicants to possess industry knowledge such as: pharmacology terminology, introduction to pharmacodynamics & pharmacogenetics, selling rules & regulations, physician selling practice etiquette, medical education, drug labeling laws, off label guidelines, and more.

Pharmaceutical Sales certification can offer a competitive advantage for most applicants but only if the content in the program prepares you for a career in pharmaceutical sales. The CNPR is certainly the most recognized in the industry and is the only program offered directly through over 300 universities. “These pharmaceutical sales training courses and accreditations are for individuals who want to enhance their selling skills to maximize their ability to get hired as well as on the job sales results. These industry standard training programs adapt each course to reflect the pharmaceutical sales model and the industry knowledge that you want your representatives to use on a day to day basis,” said Theresa Blum from Onyx Pharmaceutical.

The implementation of the Affordable Care Act has comprehensively altered the healthcare delivery landscape, creating an immediate effect of growth and change within the pharmaceutical sales industry. With that being said the CNPR pharmaceutical sales training curriculum has transformed to meet the new demands of the healthcare environment, specifically the relationship between sales reps and physicians. As physician offices and community health centers partner with large hospitals, access to physicians has diminished, creating a challenging setting for reps to share the value of pharmaceutical products with the purchasing customer.

The NAPSRx® has developed the CNPR program to educate individuals so that they will be able to differentiate themselves from other candidates. The majority of entry level candidates are not educated or qualified for the pharmaceutical industry, or its drug patents, FDA regulations, CDER regulations, laws governing the pharmaceutical industry, the anatomy, pharmaceutical terms and abbreviations, drug sampling rules, effective physician selling skills, who to contact at pharmaceutical companies, general interview questions, etc.

One reason that pharmaceutical companies prefer industry education and training is because they look to get newly hired candidates quickly out into a sales territory. If the new employee has limited training in pharmacology or the medical field then their training could last many weeks or months. This typically means no physician coverage for the assigned territory of the new employee while they are being trained. Thus the territories market share could be affected the longer it takes to train a new sales rep.

In addition, the NAPSRx® also is involved with many of the industries conferences, conventions, lobbies on bills and regulations initiated by Congress and state legislatures. It is important that Pharmaceutical Sales Representatives stay current with FDA regulations, pharmaceutical legal issues, all new clinical research, understand the pharmacodynamics of your and your competitor's products, as well as business and related practices. Our National Advisory Board and professional trainers have gained valuable experience from companies such as GlaxoSmithKline, Merck, Pfizer, Aventis, Abbot Laboratories, Forest Pharmaceuticals, Wyeth, TAP, Bausch & Lomb, Johnson &Johnson amongst many other major pharmaceutical companies. This expertise allows the NAPSRx® to monitor, train and educate successfully.